The legacy deal market has grown significantly over the last five years, with 238 deals publicly announced, transacting more than £40bn of reserves.

Actuaries at all levels interact with deal processes, and our technical expertise, numerical grounding and strategic thinking skills bring real value to our colleagues, investors and clients.

This session aims to be an approachable discussion of the topic, giving actuaries of all levels a glimpse into the deal process, and the points where actuaries can be involved.

We will touch on the technical elements of deal pricing, with discussion of the wider economic environment and strategic business goals.

We will cover:

• overview of the deal pricing process: who gets involved and when and how to spot opportunities to get involved
• buy side considerations: how legacy buyers think about deals, including pricing and non-quantitative considerations, and how different buyers think about deals
• key pricing assumptions: what they might be and how the wider economic and business environment affects them, how your strategy might change them and how to think about uncertainty
• deal pricing from the sell side: how in-house actuaries can bring their expertise to bear to help colleagues and advisors achieve the best price, and how to think about your book commercially

We will encourage lively discussion on these topics. Even the most junior trainees should feel able to contribute, while benefiting from the strategy and negotiation experience more senior attendees can bring.

Target audience and assumed knowledge level: No specialist knowledge required.

Speaker and company: Philip Jacob and Charan Maheswaran, PwC